The anti-apoptotic processes enhanced the triglyceride formation and inhibited the FFA toxicity, while the high levels of anti-apoptotic BCL-2 revealed in NAFLD suggested its protective role in disease progression (Tarantino et al., 2011). This evidence concerns the gene BCL2 and metabolic dysfunction-associated steatotic liver disease.